TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Cypromed AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
29,718
|
27,337
|
25,371 |
| Financial expenses |
133
|
88
|
40 |
| Earnings before taxes |
3,974
|
4,292
|
4,188 |
| Total assets |
15,464
|
17,381
|
14,867 |
| Current assets |
13,924
|
16,889
|
14,346 |
| Current liabilities |
9,451
|
11,567
|
9,310 |
| Equity capital |
6,013
|
5,814
|
5,558 |
| - share capital |
354
|
373
|
397 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.9%
|
33.5%
|
37.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
13.4%
|
15.7%
|
16.5% |
| Return on assets (ROA) |
26.6%
|
25.2%
|
28.4% |
| Current ratio |
147.3%
|
146.0%
|
154.1% |
| Return on equity (ROE) |
66.1%
|
73.8%
|
75.4% |
| Change turnover |
3,753
|
3,525
|
2,124 |
| Change turnover % |
14%
|
15%
|
9% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.